The identification of new biomarkers and targets for tailored therapy in human colorectal cancer (CRC) onset and progression is an interesting challenge. CRC tissue produces an excess of ox-LDL, suggesting a close correlation between lipid dysfunction and malignant transformation. Lectin-like oxidized LDL receptor-1 (LOX-1) is involved in several mechanisms closely linked to tumorigenesis. Here we report a tumor specific LOX-1 overexpression in human colon cancers: LOX-1 results strongly increased in the 72% of carcinomas (P<0.001), and strongly overexpressed in 90% of highly aggressive and metastatic tumours (P<0.001), as compared to normal mucosa. Moreover LOX-1 results modulated since the early stage of the disease (adenomas vs normal mucosa; P<0.001) suggesting an involvement in tumor insurgence and progression. The in vitro knockdown of LOX-1 in DLD-1 and HCT-8 colon cancer cells by siRNA and anti-LOX-1 antibody triggers to an impaired proliferation rate and affects the maintenance of cell growth and tumorigenicity. The wound-healing assay reveals an evident impairment in closing the scratch. Lastly knockdown of LOX-1 delineates a specific pattern of volatile compounds characterized by the presence of a butyrate derivative, suggesting a potential role of LOX-1 in tumor-specific epigenetic regulation in neoplastic cells. The role of LOX-1 as a novel biomarker and molecular target represents a concrete opportunity to improve current therapeutic strategies for CRC. In addition, the innovative application of a technology focused to the identification of LOX-1 driven volatiles specific to colorectal cancer provides a promising diagnostic tool for CRC screening and for monitoring the response to therapy.
Murdocca, M., Mango, R., Pucci, S., Biocca, S., Testa, B., Capuano, R., et al. (2016). The lectin-like oxidized LDL receptor-1: A new potential molecular target in colorectal cancer. ONCOTARGET, 7(12), 14765-14780.
Tipologia: | Articolo su rivista | |
Citazione: | Murdocca, M., Mango, R., Pucci, S., Biocca, S., Testa, B., Capuano, R., et al. (2016). The lectin-like oxidized LDL receptor-1: A new potential molecular target in colorectal cancer. ONCOTARGET, 7(12), 14765-14780. | |
IF: | Con Impact Factor ISI | |
Lingua: | English | |
Settore Scientifico Disciplinare: | Settore MED/08 - Anatomia Patologica | |
Revisione (peer review): | Esperti anonimi | |
Tipo: | Articolo | |
Rilevanza: | Rilevanza internazionale | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.18632/oncotarget.7430 | |
Stato di pubblicazione: | Pubblicato | |
Data di pubblicazione: | 2016 | |
Titolo: | The lectin-like oxidized LDL receptor-1: A new potential molecular target in colorectal cancer | |
Autori: | ||
Autori: | Murdocca, M; Mango, R; Pucci, S; Biocca, S; Testa, B; Capuano, R; Paolesse, R; Sanchez, M; Orlandi, A; Di Natale, C; Novelli, G; Sangiuolo, FC | |
Appare nelle tipologie: | 01 - Articolo su rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
570cc85808ae31998899fe12.pdf | N/A | ![]() | Open Access Visualizza/Apri |